top
Please input keywords
Database
Family Website
Eucure Biopharma
Biocytogen Boston Corp.
News events
Contact us
EN
CN
JP
KR
About us
Introduction
History
Management team
Culture
Sociology
Join us
Cooperation
Pipeline
RenMice™ HiTS Platform
Technology
Technical development
Drug development process
RenMice
Models
Animal/cell Models
Disease Models
Gene Editing
Investor Relations
Home
News events
news
Media Center
Based on the world, looking to the future
news
Events
Webinar
Publication
Download
Biocytogen Enters into Antibody Agreement with ADC Therapeutics
2022.11.28
First Patient Dosed in Phase 1/2 Trial Evaluating YH001 in Combination with Envafolimab and Doxorubicin in Front Line Sarcoma Patients
2022.11.22
Biocytogen to Present a Booth at SITC 2022
2022.11.08
Year
All
2022
2021
Month
All
January
February
March
April
May
June
July
August
September
October
November
December
+86-010-56967680
info@bbctg.com.cn
Copyright © 2022 Biocytogen. All Rights Reserved
Powered by Fractal-technology